The environmental monitoring of air pollution in the Santa Cruz industrial district of Rio de Janeiro using a plant fertility model.

In 2010, a steel company was established in Santa Cruz, Rio de Janeiro. In 2012, silver rain raised concerns about human and environmental impacts. In 2013, the steel company signed an Adjustment of Conduct Term (ACT). To evaluate air pollution in the vicinity of the steel company based on a plant fertility assay before and after ACT implementation. A pollen abortion assay was implemented using flower buds of Bauhinia forficata in 2013 and Delonix regia in 2015. Sites over 5 km from the steel company, highways, and tunnels were classified as unexposed; sites 5 km from highway/tunnel were classified as exposed to other sources; and sites 5 km from the steel company were classified as exposed. Random plant collection occurred during the dry and rainy seasons (10 buds/site and 300 cells/slide). Aborted grains were analyzed using a 400-fold magnification microscope. Statistical analyses were considered significant at the 5% level. In 2013 were collected flower buds in 27 sites (2 unexposed, 18 highway/tunnel-exposed, and 7 steel company-exposed); and 34 sites in 2015 (14 unexposed, 18highway/tunnel-exposed, and 2 steel company-exposed). In both years, the mean pollen abortion was significantly higher in the dry season for sites exposed to highway/tunnel (p < 0.001) and the steel company (p = 0.005). In 2013, the mean pollen abortion was significantly higher in sites exposed to highway/tunnel compared to unexposed sites (p = 0.004) and in sites exposed to the steel company compared to sites exposed to highway/tunnel (p = 0.034). In 2015, compared to unexposed sites, the mean pollen abortion was significantly higher in sites exposed to highway/tunnel (p = 0.014) and the steel company (p < 0.001). Overall, compared to unexposed sites, the mean pollen abortion was 5.79-fold higher in sites exposed to the steel company and 4.08-fold higher in sites exposed to highway/tunnel. Compared to unexposed plants, greater air pollution effects occurred in plants exposed to the steel company before (2013) and after (2015)ACT implementation.

TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions.

The purpose of this study was to determine the prevalence of TP53 polymorphism at codon 72 and its association with environmental risk factors in a sample of women in Rio de Janeiro, Brazil. A cross-sectional study was conducted with 304 women with histological diagnoses of negative, precancerous, and cancerous lesions between October 2004 and May 2006. Antecedents of exposure to environmental risk factors were ascertained through an interview-administered questionnaire, and whenever indicated, colposcopy tests and lesion excisions were performed. Genomic DNA was extracted from leukocytes of peripheral blood subjects, and genotyping of TP53 polymorphism was conducted using polymerase chain reaction and restriction fragment-length polymorphism methods. Crude and adjusted odds ratios (OR) and their 95% confidence intervals (CI) were ascertained for selected risk factors and allelic groups among control, low-grade squamous intraepithelial lesion (LSIL), and high-grade squamous intraepithelial lesion (HSIL)/cancer strata, using logistic regression analysis. The TP53 polymorphism distribution in this population was 64 (21.1%) Arg/Arg, 55 (18.1%) Pro/Pro, and 185 (60.9%) Arg/Pro. Women who were heterozygous (Arg/Pro) showed an independent risk for cervical HSIL/cancer (adjusted OR: 1.92, 95%CI: 1.03-1.59, controlled for age, ethnicity, and age at menarche) compared to Pro/Pro genotypic women. Age at sexual onset up to 16 yr old (adjusted OR: 1.97, 95%CI: 1.18-3.3), lifelong 3-4 sexual partners (adjusted OR: 2.38, 95%CI: 1.32-4.28), current smoking (adjusted OR: 2.32, 95%CI: 1.31-4.13), and smoking more than 10 yr (adjusted OR: 2.52, 95%CI: 1.042-6.09) were found to be independent risk factors for cervical HSIL/cancer. Women possessing the Arg/Pro genotype presented a higher risk for HSIL/cancer development compared to Pro/Pro genotypic women in the sample studied after control for selected confounders. Early sexual onset, multiple sexual partners, and current and past tobacco smoking were independent risk factors for HSIL/cancer development.

Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country.

PURPOSE: To estimate treatment delays and associated factors among women diagnosed with cervical cancer who were treated at the main cancer center in Rio de Janeiro, Brazil. MATERIALS AND METHODS: A retrospective cohort study was performed comprising 865 women newly diagnosed with cervical cancer between 2012 and 2014. Times from diagnosis to treatment initiation (less than or equal to 60 days) and from diagnosis to treatment ending (less than or equal to 120 days) were analyzed according to the Brazilian law for the treatment of patients with cancer. Associations between treatment delays and sociodemographic, economic, lifestyle, clinical, and treatment variables were estimated using logistic regression models, with 95% CIs. RESULTS: The average age was 48 (± 13.7) years, and the median age was 47 years; 36.2% of patients had stage IIIB to IVA disease. The median time from diagnosis to treatment initiation was 114 days, which was statistically higher among women with stage IIB to IVA (105.5 days) compared with those with earlier stages (119 days). The delay in treatment initiation occurred in 92.8% of participants; the median time from diagnosis to treatment ending was 274 days, with a delay (more than 120 days) for 92.6% of patients. The median time interval from diagnosis to the first visit to the cancer center was 28 days, with a delay of more than 30 days for 46.6% of patients. Age (odds ratio [OR], 1.05; 95% CI,1.02 to 1.08), stage IIIB to IVA (OR, 0.38; 95% CI, 0.16 to 0.90), time to first visit to the cancer center (OR, 11.52; 95% CI, 4.32 to 30.66), chemoradiation treatment (OR, 4.56; 95% CI, 1.81 to 11.47), and adequate treatment (OR, 2.57; 95% CI, 1.26 to -5.40) were independently associated with delay of treatment initiation. CONCLUSION: Significant delays in treatment initiation and ending were observed in this studied population. The treatment initiation delay was positively associated with age, time interval more than 30 days from diagnosis to first specialist assessment at the cancer center, treatment with chemoradiation, and adequate treatment.